NDC Code(s) : 60687-141-11, 60687-141-21
Packager : American Health Packaging
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
Dextroamphetamine SulfateDextroamphetamine Sulfate CAPSULE, EXTENDED RELEASE | ||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
PRINCIPAL DISPLAY PANEL
NDC 60687-141-21
DEXTROAMPHETAMINE
SULFATE
Extended-Release
Capsules
CII
10 mg
30 Capsules (3 x 10)
PHARMACIST: Dispense with the accompanying
Medication Guide to each patient.
Each Capsule Contains:
Dextroamphetamine Sulfate, USP …………. 10 mg
so prepated that an intitial dose is released promtly and
the remaining medication is released gradually over a
prolonged period.
Usual Dosage: See package insert for full prescribing
information.
Store at 20° to 25°C (68° to 77°F); excursions permitted
between 15° to 30°C (59° to 86°F) [see USP Controlled
Room Temperature].
DEA Order Form Required.
Keep this and all drugs out of reach of children.
Rx Only
The drug product contained in this package is
from NDC # 0555-0955, Teva Pharmaceuticals
USA.
Packaged and Distributed by:
American Health Packaging
Columbus, Ohio 43217
714121
Rev. 02/2015